Attached files
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In
connection with this Quarterly Report of MusclePharm Corporation
(the “Company”), on Form 10-Q for the quarter ended
September 30, 2017, as filed with the U.S. Securities and Exchange
Commission on the date hereof (the “Report”), I, Ryan
Drexler, Principal Accounting Officer and Principal Financial
Officer of the Company, certify pursuant to 18 U.S.C. Section.
1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act
of 2002, that to the best of my knowledge:
(1)
The Report fully
complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, as amended; and
(2)
The information
contained in the Report, fairly presents, in all material respects,
the financial condition and results of operations of the
Company.
|
|
|
|
|
|
Date:
November 14, 2017
|
|
By:
|
/s/ Ryan Drexler
|
|
|
|
Ryan
Drexler
Chief
Executive Officer, President, and Chairman
|
|
|
|
|
(Principal
Accounting Officer and
Principal Financial
Officer)
|